Abstract
Rho proteins participate in the regulation of inflammatory gene expression in endothelial cells. We made use of Clostridium difficile toxin B-10643 (TcdB-10463) which inhibites RhoA/Rac1/Cdc42 to analyze their role in expression and regulation of cyclooxygenase-2 (COX-2) in endothelial cells (EC). Pretreatment of EC with TcdB-10643 prevented lipopolysaccharide (LPS)- or tumor necrosis factor-α (TNFα )-related COX-2 expression but had no effect on COX-1 protein levels. TcdB-10463 preincubation suppressed LPS-dependent nuclear factor-κB activation (NF-κ B). Rho inhibition did not affect COX-1 activity. Inactivation of Rho proteins before LPS stimulation blocked arachidonic acid (AA)-, thrombin-, and Escherichia coli hemolysin (HlyA)-dependent release of COX-2-related 6-ketoprostaglandin F1α (6k-PGF1α). In contrast, Rho inhibition did not affect COX-2-dependent 6k-PGF1α liberation when TcdB-10643 was added 10 h after LPS or TNFα stimulation of EC. Therefore, RhoA/Rac1/Cdc42 contribute to NF-κ B-dependent LPS- and TNFα-induced expression of PGHS-2 in EC but had no effect on the activity of expressed COX-1 and COX-2.
Similar content being viewed by others
References
Davidge, S. T. 2001. Prostaglandin H synthase and vascular function. Circ. Res. 89:650–660.
Mitchell, J. A. and T. W. Evans. 1998. Cyclooxygenase-2 as a therapeutic target. Inflamm. Res. 47: S88-S92.
Smith, W. L., D. L. DeWitt, and R. M. Garavito. 2000. Cyclooxygenases: Structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145–182.
Suttorp, N., W. Seeger, and H. Neuhof. 1989. Effects of bacterial exo-and endotoxins on endothelial arachidonate metabolism. Prog. Clin. Biol. Res. 308:119–125.
Suttorp, N., W. Seeger, E. Dewein, S. Bhakdi, and L. Roka. 1985. Staphylococcal alpha-toxin-induced PGI2 production in endothelial cells: Role of calcium. Am. J. Physiol. 248: C127-C134.
Suttorp, N., B. Floer, H. Schnittler, W. Seeger, and S. Bhakdi. 1990. Effects of Escherichia coli hemolysin on endothelial cell function. Infect. Immun. 58:3796–3801.
Wu, K. K. and P. Thiagarajan. 1996. Role of endothelium in thrombosis and hemostasis. Annu. Rev. Med. 47:315–331.
Jones, D. A., D. P. Carlton, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 1993. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268:9049–9054.
Degraeve, F., M. Bolla, S. Blaie, C. Creminon, I. Quere, P. Boquet, S. Levy-Toledano, J. Bertoglio, and A. Habib. 2001. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. J. Biol. Chem. 276:46849–46855.
Slice, L. W., J. H. Walsh, and E. Rozengurt. 1999. Galpha(13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter. J. Biol. Chem. 274:27562–27566.
Slice, L. W., L. Bui, C. Mak, and J. H. Walsh. 2000. Differential regulation of COX-2 transcription by Ras-and Rho-family of GTPases. Biochem. Biophys. Res. Commun. 276:406–410.
Subbaramaiah, K., J. C. Hart, L. Norton, and A. J. Dannenberg. 2000. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275:14838–14845.
Thomas, W., Z. K. Ascott, D. Harmey, L. W. Slice, E. Rozengurt, and A. J. Lax. 2001. Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 gene. Infect. Immun. 69:6839–6845.
Just, I., J. Selzer, M. Wilm, C. v. Eichel-Streiber, M. Mann, and K. Aktories. 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375:500–503.
Just, I., F. Hofmann, and K. Aktories. 2000. Molecular mode of action of the large clostridial cytotoxins. Curr. Top. Microbiol. Immunol. 250: 55–83.
Hippenstiel, S., S. Tannert-Otto, N. Vollrath, M. Krüll, I. Just, K. Aktories, C. v. Eichel-Streiber, and N. Suttorp. 1997. Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am. J. Physiol. 272: L38-L43.
Hippenstiel, S., T. Kratz, M. Krüll, J. Seybold, C. v. Eichel-Streiber, and N. Suttorp. 1998. Rho protein inhibition blocks protein kinase C translocation and activation. Biochem. Biophys. Res. Commun. 245:830–834.
Hippenstiel, S., S. Soeth, B. Kellas, O. Fuhrmann, J. Seybold, M. Krüll, C. v. Eichel-Streiber, M. Goebeler, S. Ludwig, and N. Suttorp. 2000. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95:3044–3051.
Hippenstiel, S., B. Schmeck, J. Seybold, M. Krüll, C. v. Eichel-Streiber, and N. Suttorp. 2002. Reduction of tumor necrosis factor-alpha (TNF-α) related nuclear factor-kappaB (NF-κB) translocation but not inhibitor kappa-B (Iκ-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem. Pharmacol. 64:973–979.
Moos, M., and C. v. Eichel-Streiber. 2000. Purification and evaluation of large clostridial cytotoxins that inhibit small GTPases of Rho and Ras subfamilies. Methods Enzymol. 325:114–425.
Krüll, M., A. C. Klucken, F. N. Wuppermann, O. Fuhrmann, C. Magerl, J. Seybold, S. Hippenstiel, J. H. Hegemann, C. A. Jantos, and N. Suttorp. 1999. Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J. Immunol. 162:4834–4841.
Takai, Y., T. Sasaki, and T. Matozaki. 2001. Small GTP-binding proteins. Physiol. Rev. 81:153–208.
Nieuw Amerongen, G. P., S. van Delft, M. A. Vermeer, J. G. Collard, and V. W. van Hinsbergh. 2000. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ. Res. 87:335–340.
Tzima, E., M. A. del Pozo, S. J. Shattil, S. Chien, and M. A. Schwartz. 2001. Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J. 20:4639–4647.
Essler, M., J. M. Staddon, P. C. Weber, and M. Aepfelbacher. 2000. Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J. Immunol. 164:6543–6549.
Takeuchi, S., S. Kawashima, Y. Rikitake, T. Ueyama, N. Inoue, K. Hirata, and M. Yokoyama. 2000. Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC. Biochem. Biophys. Res. Commun. 269: 97–102.
Hippenstiel, S., B. Schmeck, P. Dje N'Guessan, J. Seybold, M. Krüll, K. Preissner, C. v. Eichel-Streiber, and N. Suttorp. 2002. Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 283: L830-L838.
Hahn, A., H. Barth, M. Kress, P. R. Mertens, and M. Goppelt-Struebe. 2002. Role of Rac and Cdc42 in lysophosphatidic acid-mediated cyclo-oxygenase-2 gene expression. Biochem. J. 362:33–40.
Kim, B. C. and J. H. Kim. 1998. Exogenous C2-ceramide activates c-fos serum response element via Rac-dependent signalling pathway. Biochem. J. 330:1009–1014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmeck, B., Brunsch, M., Seybold, J. et al. Rho Protein Inhibition Blocks Cyclooxygenase-2 Expression by Proinflammatory Mediators in Endothelial Cells. Inflammation 27, 89–95 (2003). https://doi.org/10.1023/A:1023278600596
Issue Date:
DOI: https://doi.org/10.1023/A:1023278600596